Improving Prevention Systems to Reduce Disparities for High Priority Populations.

改进预防系统,减少高优先人群的差异。

基本信息

  • 批准号:
    10088339
  • 负责人:
  • 金额:
    $ 60.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-05-01 至 2023-01-31
  • 项目状态:
    已结题

项目摘要

7. PROJECT SUMMARY This project collaborates with the New York City Department of Health and Mental Hygiene (NYC DOHMH) to develop and test a field-based comprehensive sexual health intervention for HIV-exposed contacts notified by its Partner Services (i.e., HIV contact tracing) program. Individuals reached by PS programs are highest priority for linkage to HIV prevention/care services: 10-20% are newly diagnosed with HIV as a result of PS notification and the remainder are eligible and high priority for PrEP. Because they seek out highest-risk individuals in the field, PS programs have the potential to significantly reduce existing disparities in PrEP uptake and timely HIV care initiation by reaching populations that are currently under-engaged by traditional PrEP or HIV testing programs. The new Partner Services-Sexual Health (PS-SH) intervention offers a comprehensive sexual health package that includes HIV testing, STI testing, ARV/PrEP education and immediate medication start to all individuals receiving contact notification (i.e., being notified of a recent exposure to HIV). NYCDOHMH is collaborating on this research project to enable a scientifically rigorous test of the intervention’s efficacy and produce the highest quality data on implementation dynamics, cost-effectiveness, and affordability to inform dissemination and adaptation of the intervention, should it prove effective. The specific aims are to: (1) Pilot and refine a field-based comprehensive sexual health intervention delivered through the NYC DOHMH Partner Services Program. Under this aim, we will pilot the intervention in five highest prevalence NYC neighborhoods for 6-months (n = ~60), examine feasibility and acceptability, and refine the intervention process and protocols for the trial to test effectiveness at scale. (2) Examine the effectiveness of the Partner Services-Sexual Health (PS-SH) intervention in improving rates of HIV testing, linkage to HIV prevention/care, and PrEP uptake among highest risk contacts recently exposed to HIV. Under this aim, we will conduct a cross-sectional stepped wedge cluster randomized trial in which 12 clusters of NYC neighborhoods are exposed to the intervention sequentially, with three clusters moving from control to intervention every 6 months (n = 1150). Primary outcomes are HIV testing, timely PrEP/ARV uptake, and linkage to PrEP/HIV care. Secondary outcomes are STD testing and receipt of STD treatment (if indicated). (3) Conduct preliminary analyses of economic outcomes, including cost-allocation and affordability to allow other jurisdictions to make decisions about implementation. These analyses will include per-outcome cost-estimates, and will develop a blueprint for economic evaluation of the intervention including incremental cost-effectiveness and budget impact analyses for application locally and nationally. The proposed project is poised to have a significant and sustained impact on the field by: a) addressing a critical gap in the prevention/care continuum to reduce persistent disparities in the epidemic; and b) pioneering a collaborative implementation science approach to accelerate the dissemination of evidence-based practice models across the United States and internationally.
7.项目摘要 该项目与纽约市卫生和心理卫生部(NYC DOHMH)合作, 为已通知的艾滋病毒接触者制定并测试基于实地的全面性健康干预措施, 其合作伙伴服务(即,艾滋病毒接触者追踪)计划。PS计划覆盖的个人是最高优先级 与艾滋病毒预防/护理服务的联系:10-20%是由于PS通知而新诊断出的艾滋病毒感染者 其余的人都有资格获得PrEP的高优先级。因为他们在人群中寻找风险最高的人。 在该领域,PS计划有可能显着减少PrEP吸收和及时艾滋病毒的现有差距 通过接触目前未充分参与传统PrEP或艾滋病毒检测的人群来启动护理 程序.新的合作伙伴服务-性健康(PS-SH)干预提供了一个全面的性 包括艾滋病毒检测、性传播感染检测、抗逆转录病毒/预防前预防教育和立即用药在内的一揽子健康计划开始, 所有接收联系通知的个人(即,被告知最近暴露于艾滋病毒)。NYCDOHMH是 合作开展这项研究项目,以便对干预措施的有效性进行科学严格的测试, 提供有关实施动态、成本效益和可负担性的最高质量数据, 如果干预措施证明是有效的,则进行传播和调整。具体目标是:(1)试点 并完善通过纽约市卫生和家庭健康部合作伙伴提供的基于实地的全面性健康干预措施 服务计划。在这个目标下,我们将在纽约市五个患病率最高的社区进行试点干预 为期6个月(n = ~60),检查可行性和可接受性,并完善干预过程和方案 进行大规模的有效性试验(2)检查伙伴服务-性健康的有效性 (PS-SH)干预措施,以提高艾滋病毒检测率,与艾滋病毒预防/护理的联系, 最近接触过艾滋病毒的高危接触者在此目标下,我们将进行一个横截面阶梯楔 一项随机分组试验,其中12组纽约市社区暴露于干预措施 按顺序,每6个月从对照组转移到干预组(n = 1150)。初级 结果是艾滋病毒检测,及时的PrEP/ARV摄取,以及与PrEP/艾滋病毒护理的联系。次要结局 性病检测和接受性病治疗(如有指征)。(3)进行初步经济分析 结果,包括成本分配和负担能力,以允许其他司法管辖区作出决定, 实施.这些分析将包括每个结果的成本估计,并将制定蓝图, 对干预措施进行经济评价,包括增量成本效益和预算影响分析 适用于本地和全国。拟议的项目将产生重大和持续的影响 (a)解决预防/护理连续体中的一个关键差距, B)开创一种合作实施科学方法, 在美国和国际上传播基于证据的实践模式。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sarit A Golub其他文献

Sarit A Golub的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sarit A Golub', 18)}}的其他基金

Trauma-Informed Investigation of TGNBI Experiences in HIV Stigma Research
TGNBI 在 HIV 耻辱研究中的经历的创伤知情调查
  • 批准号:
    10646313
  • 财政年份:
    2022
  • 资助金额:
    $ 60.16万
  • 项目类别:
Trauma-Informed Investigation of TGNBI Experiences in HIV Stigma Research
TGNBI 在 HIV 耻辱研究中的经历的创伤知情调查
  • 批准号:
    10548304
  • 财政年份:
    2022
  • 资助金额:
    $ 60.16万
  • 项目类别:
Implementation Research to Enhance Equity- Focused HIV Prevention in New York City
加强纽约市以公平为重点的艾滋病毒预防的实施研究
  • 批准号:
    10645068
  • 财政年份:
    2021
  • 资助金额:
    $ 60.16万
  • 项目类别:
Implementation Research to Enhance Equity- Focused HIV Prevention in New York City
加强纽约市以公平为重点的艾滋病毒预防的实施研究
  • 批准号:
    10460103
  • 财政年份:
    2021
  • 资助金额:
    $ 60.16万
  • 项目类别:
Implementation Research to Enhance Equity- Focused HIV Prevention in New York City
加强纽约市以公平为重点的艾滋病毒预防的实施研究
  • 批准号:
    10336187
  • 财政年份:
    2021
  • 资助金额:
    $ 60.16万
  • 项目类别:
Synthesizing Best Practice to Accelerate Access to Emerging HIV Prevention Modalities
综合最佳实践以加速获得新兴艾滋病毒预防方式
  • 批准号:
    10209311
  • 财政年份:
    2020
  • 资助金额:
    $ 60.16万
  • 项目类别:
Synthesizing Best Practice to Accelerate Access to Emerging HIV Prevention Modalities
综合最佳实践以加速获得新兴艾滋病毒预防方式
  • 批准号:
    10579917
  • 财政年份:
    2020
  • 资助金额:
    $ 60.16万
  • 项目类别:
Synthesizing Best Practice to Accelerate Access to Emerging HIV Prevention Modalities
综合最佳实践以加速获得新兴艾滋病毒预防方式
  • 批准号:
    10361470
  • 财政年份:
    2020
  • 资助金额:
    $ 60.16万
  • 项目类别:
Synthesizing Best Practice to Accelerate Access to Emerging HIV Prevention Modalities
综合最佳实践以加速获得新兴艾滋病毒预防方式
  • 批准号:
    10012324
  • 财政年份:
    2020
  • 资助金额:
    $ 60.16万
  • 项目类别:
Biomedical Prevention Adherence Dynamics in a High Priority Population
高优先人群的生物医学预防依从动态
  • 批准号:
    9558421
  • 财政年份:
    2018
  • 资助金额:
    $ 60.16万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 60.16万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.16万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 60.16万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.16万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 60.16万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.16万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 60.16万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 60.16万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 60.16万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.16万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了